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Summary
Objective: To elucidate the antagonism between interleukin-1 (IL-1) and transforming growth factor-b (TGF-b) at the gene expression level, as
IL-1 and TGF-b are postulated to be critical mediators of cartilage degeneration/protection in rheumatic diseases.
Methods: The H4 chondrocyte cell line was validated by comparing metalloproteinase expression proﬁle with intact murine cartilage by
reverse transcription polymerase chain reaction. Genome-wide gene expression in the H4 cells in response to IL-1 and TGF-b, alone and in
combination, was analyzed by using oligonucleotide arrays negotiating approximately 12,000 genes.
Results: The response of cartilage and the H4 cell line to IL-1 and TGF-b was comparable. Oligonucleotide array analysis demonstrated
a mutual but asymmetrical antagonism as the dominant mode of interaction between IL-1 and TGF-b. Cluster analysis revealed a remarkable
selectivity in the mode of action exerted by TGF-b on IL-1 regulated genes: antagonistic on pro-inﬂammatory genes whereas additive on
growth regulators such as vascular endothelial growth factor (VEGF) and connective tissue growth factor (CTGF). While the former cluster
underlined the protective effect of TGF-b, the latter underscored the adverse effect of TGF-b. We further identiﬁed potentially novel classes of
target genes under control of TGF-b such as ras family, histones, proteasome components, and ubiquitin family, highlighting the importance of
such genes in TGF signaling besides the well-characterized SMAD pathway.
Conclusions: We identiﬁed a cluster of genes as potential targets mediating the adverse effect of TGF-b such as ﬁbrosis. Transcriptional
regulation of ras GTPase and ubiquitin/proteasome pathways is likely to be a novel mechanism mediating the effect of TGF-b and its
interaction with IL-1. These down-stream genes and pathways can be targets in future therapy.
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Cartilage
Repair
SocietyIntroduction
Osteoarthritis (OA) is the joint disease with the highest
prevalence in the human population, and is characterized
by destruction of articular cartilage and loss of joint function.
The etiopathology of OA is not clear until today but
activation of articular chondrocytes triggered by interleu-
kin-1 (IL-1) appears to be a likely scenario1. Exposure of
chondrocytes to IL-1 results in altered chondrocyte gene
expression characterized by production of, amongst others,
proteases and nitric oxide. Genes speciﬁc for functional
chondrocytes, e.g., aggrecan and type II collagen, are
switched off due to this process. Eventually, chondrocyte
metabolism and phenotype are altered resulting in the
inability of these cells to maintain intact, functional articular
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but also other enzymes like aggrecanases a disintegrin and
metalloproteinase with thrombospondin 1-like motifs
(ADAMTS4/5), are involved in active destruction of the
cartilage matrix1.
Transforming growth factor-b (TGF-b) has been sug-
gested to be a protective factor for articular cartilage.
Inhibition of TGF-b signaling in murine joint tissues by
overexpression of a kinase-defective TGF-b receptor or by
inactivation of the intracellular signaling molecule SMAD 3,
resulted in the development of OA2. Our own group has
shown that TGF-b counteracts the catabolic effects of IL-1
on articular cartilage in vitro and in vivo3,4. Moreover, we
also showed that in vivo inhibition of endogenous TGF-
b activity in an OA model, using a soluble form of the type II
TGF-b receptor, results in increased proteoglycan loss and
cartilage degradation5, indicating that TGF-b itself protects
cartilage against damage. In vitro studies have shown that
TGF-b increases the synthesis of protease inhibitors such
as tissue inhibitor of metalloproteinase (TIMP) and de-
creases the production of several MMPs in chondrocytes6.
The production of NO stimulated by IL-1 is counteracted by
TGF-b7. In addition, TGF-b is able to increase the pro-
duction of essential cartilage matrix molecules such as
aggrecan and type II collagen8. From these data it can be
concluded that TGF-b counteracts cartilage degradation6
427Osteoarthritis and Cartilage Vol. 13, No. 5and the development of OA. However, other studies have
shown that TGF-b can induce the synthesis of MMP-13
(collagenase-3) in a subpopulation of human articular
chondrocytes9 or MMP-9 in normal equine chondrocytes10.
In synovial lining cells, TGF-b has been shown to increase
the synthesis of aggrecanases (ADAMTS4/5) which could
result in accelerated breakdown of aggrecan in cartilage11.
Moreover, repeated local administration of TGF-b at high
concentration resulted in OA-like changes in articular
cartilage12. Therefore, the precise role of TGF-b in the
pathogenesis of OA remains inconclusive.
The goal of this study was to investigate via which
pathways TGF-b interacts with the catabolic effects of IL-1
on articular chondrocytes on the gene expression level.
This will lead to better insight in the functional role of TGF-
b in OA and other cartilage-related diseases. Therefore,
regulation of gene expression by IL-1, TGF-b and the
combination of both agents was studied in a murine
chondrocyte cell line H4, which was previously developed
in our group. This cell line has been shown to express
aggrecan mRNA and type II collagen mRNA and protein,
and IL-1 strongly inhibited proteoglycan synthesis and
stimulated nitric oxide synthesis in this cell line13. All these
features are characteristics of differentiated articular chon-
drocytes. To validate this model system, the IL-1-induced
expression of a number of MMPs in this murine cell line was
compared with IL-1-induced MMP expression in intact
patellar cartilage of mice. IL-1-induced regulation of the
MMPs on mRNA level in the murine H4 cell line appeared to
be comparable to expression regulation in intact murine
cartilage in vivo. Therefore, this cell line was chosen as
a valid model system to study the interaction between IL-1
and TGF-b.
Methods
ANIMALS
Male C57BL/6 mice aged 12 weeks were used. Animals
were fed a standard diet and had access to tap water ad
libitum.
EXPRESSION OF MMP IN MURINE PATELLAE IN VIVO
To study the expression of MMP-3, -9, -13, -14 in patellar
chondrocytes after stimulation by IL-1, the right knees of
male C57BL/6 mice were injected with 10 ng recombinant
murine IL-1a. Animals were sacriﬁced after 3, 6, 12 and
24 h and both the injected and the non-injected knee joints
were isolated. RNA was isolated from patellar cartilage as
described14. In short, patellae were dissected from murine
knee joints and immediately decalciﬁed at 4(C in 3.5%
ethylenediaminetetraacetic acid (EDTA) (Sigma) for 16 h.
Following decalciﬁcation the complete articular cartilage
layer was stripped from the underlying bone. Total RNA
was isolated using the RNeasy method as described by the
supplier (Qiagen Inc, Valencia, CA, USA), and quality of
RNA was veriﬁed. In all reverse transcription polymerase
chain reaction (RT-PCR) experiments, cartilages from 10
patellae were pooled. The relative expression of MMP-3, -9,
-13 and -14 was assayed by semi-quantitative RT-PCR.
CHONDROCYTE CULTURE AND RNA ISOLATION
H4 chondrocytes derived from hip articular cartilage from
adult C57BL/6 mice were used13. Cells were seeded at
density of 8! 104 cells/cm2 in a six-well plate or in a cultureﬂask, pre-incubated 16 h in Dulbecco’s modiﬁed Eagle
medium (DMEM) medium supplemented with 10% fetal calf
serum and penicillin (100 units/ml)/streptomycin (100 mg/
ml). Cells were incubated with IL-1a (10 ng/ml) or TGF-b1
(10 ng/ml) alone or a combination of both factors for 9 h.
This time point was based on the prior kinetic experiment
with IL-1. Chondrocytes were detached from the culture
disk in RNase free lysis buffer (Qiagen), and kept frozen at
80(C till analyzed. The lysate was further processed to
isolate total RNA by using RNeasy kit (Qiagen). The RNA
was quantiﬁed by using ﬂuorescent dye riboGreen (Molec-
ular Probes Europe, Leiden) according to the manufactur-
er’s instruction. The RNA was used for semi-quantitative
RT-PCR and hybridization to oligonucleotide arrays.
SEMI-QUANTITATIVE PCR
The RNA isolated from the cartilage was treated with
DNAse I (Life Technologies Inc., Breda) according to the
supplier’s instructions. The RT reaction was performed,
PCR was carried out, and electrophoresed as described15.
The cycle number at which the product was ﬁrst detected
was taken as a measure for the amount of speciﬁc mRNA.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
mRNA levels were used as an internal control. All RT-
PCR reactions were performed in duplicate. Primer
sequences for MMPs and GAPDH were selected with the
computer programs Primer (Whitehead Institute, Cam-
bridge, MA) using sequence data from international data
banks. Statistical signiﬁcance of change in multiple experi-
ments was assessed by using student’s t test with Welch’s
correction.
QUANTITATIVE PCR
Primers used for quantitative PCR (aggrecan and MMP-
3) were selected using the primer Express software
(Applied Biosystems, Capelle, The Netherlands). cDNA
was obtained as described above. For ampliﬁcation of the
samples 300 nM of each primer, cDNA and Sybr Green
PCR master mix (Applied Biosystems) containing dNTPs,
MgCl2 and AmpliTaq Gold were mixed (total volume 25 ml).
Ampliﬁcation and detection were carried out using an ABI
Prism 7000 sequence detection system under the following
conditions: 10 min at 95(C and 40 cycles of 15 s at 95(C
and 1 min at 60(C. During ampliﬁcation DNA quantity was
continuously monitored by quantitative analysis of the
ﬂuorescence emission. [Tables I(A) and III(A) enlists the
sequence of all primers for both semi-quantitative and
quantitative PCR.]
HYBRIDIZATION TO OLIGONUCLEOTIDE ARRAY (GENECHIP)
The protocols from Affymetrix (Santa Clara, CA) were
followed (Expression Analysis Technical Manual, Affyme-
trix, 2001) as described previously16. Synthesis of double-
stranded cDNA from 5 mg total RNA using an oligo dT
primer with the T7 RNA polymerase recognition sequence
appended was performed using the SuperScript Choice
System (Invitrogen), followed by in vitro transcription/biotin
labeling with T7 RNA polymerase using the BioArray High
Yield RNA Transcript Labeling Kit (Enzo Diagnostics, NY,
USA). After fragmenting the biotin labeled transcripts, the
hybridization mixture was spiked with Bio B, C, D and cre
for control of arrays. The murine genome array chip,
MGU74Av2 (Affymetrix) was used. MGU74Av2 contained
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RT-PCR in murine patellar cartilage and murine chondrocyte cell line. A. Primers used for the quantitative and semi-quantitative RT-PCR. The
primer pairs used for quantitative and semi-quantitative RT-PCR are enlisted. The primers were designed as described in Materials and
methods. The sequence depicts 5# to 3#. * Tested by quantitative PCR, # number. B. Relative MMP expression in murine patellar cartilage
after IL-1 injection. MMP expression was compared to control knee joint. Expressed is the fold changes compared to control patellar cartilage
(based on difference in number of cycles after which the amplicon of the investigated gene was detected visually). C. Relative MMP
expression in a murine chondrocyte cell line after addition of IL-1, TGF-b, or a combination of IL-1 and TGF-b. MMP expression was compared
to control level, and expressed as fold changes. RNA was isolated 9 h after addition of the factors. The table shows meanG S.E.M. out of four
independent experiments. *P! 0.05, **P! 0.002 compared to IL-1 treatment
A.
Gene Gene bank accession # Forward primer Reverse primer
Mmp-3 X66402 TAGAAAACTACTATGGCCTTGC CGAGATCATTATGTCAGCCTC
Mmp-9 NM_013599 GGCTCCTTCTTTGCTTCAAC CACAAAAGCCAGCTGATTCA
Mmp-13 X66473 GCCATTACCAGTCTCCGAGGA GGAATTTGTTGGCATGACTCTCAC
Mmp-14 NM_008608 AGAGGGTCATTCATGGGCAG TCCCATGGCGTCTGAAGAAG
Gapdh NM_008084 AACTCCCTCAAGATTGTCAGCA TCCACCACCCTGTTGCTGTA
B.
Hours after
IL-1 injection
Mmp-3 Mmp-9 Mmp-13 Mmp-14
3 64 4 4 4
6 16,384 4 4 4
12 65,536 4 256 16
24 4096 1 1 4
C.
Cytokine Mmp-3 Mmp-9 Mmp-13 Mmp-14
IL-1 7.00G 1.30 37.00G 6.83 18.50G 6.57 34.00G 7.50
TGF-b 0.75G 0.35** 2.00G 1.41** 0.38G 0.44** 0.19G 0.09**
IL-1C TGF-b 2.50G 1.50 10.00G 6.00 0.63G 0.38* 2.50G 1.50*approximately 12,000 characterized genes and Expressed
sequence tags (ESTs). After 16 h of hybridization in the
GeneChip Hybridization oven 640 (Affymetrix) at 60 rpm at
45(C the GeneChips were washed in the GeneChip
Fluidics Station 400 (Affymetrix) and the biotin groups
reacted with streptavidin coupled phycoerythrin (Molecular
Probes, OR, USA). Antibody enhancement was used
during washing. The GeneChips were then scanned using
a laser scanner (Hewlett Packard, HP G2500A GeneArray
scanner) according to the manufacturer’s instruction. Test
arrays as well as gel analysis (Ambion, Austin, USA) were
used to verify integrity of RNA samples, and reproducibility
of the expression proﬁle was examined on a number of
MMP genes by RT-PCR.
DATA ANALYSIS
Hybridization results were captured and further pro-
cessed using the Microarray Suite (MAS) 5.0 software
(Affymetrix, Santa Clara, CA). Absolute expression analysis
was performed on each chip, and all possible combinations
of pair-wise comparison analysis were performed. MAS 5.0
runs the statistical algorithm using a one-sided Wilcoxon’s
signed rank test applied to 16 probe pairs consisting of both
perfect match and mismatch sequences. For absolute
expression analysis, P! 0.04 is considered to be a signal.
For comparative analysis, two intensity data originating
from two hybridization results were adjusted by scaling
using all probe sets against 100 target signals. P value is
determined by a signed rank analysis. P! 0.003 is
considered to be signiﬁcant increase, whereas PO 0.997
is considered to be signiﬁcant decrease. By use of MAS 5.0
the false change rate was shown to be less than 0.2 % foran identical sample (Affymetrix technical note), and our
previous results veriﬁed extremely high reproducibility of
GeneChip data16,17. Gene annotation was down-loaded
from the database of Affymetrix NetAffx Analysis Center
(Affymetrix, Santa Clara, CA) in reference to NCBI (NCBI,
Bethesda), Unigene and GeneOntology (http://www.
geneontology.org). All ESTs and some full-length sequen-
ces were compared to the GenBank database sequences
using the BLAST algorithm. Hierarchical clustering
(M. Eisen, http://rana.lbl.gov/EisenSoftware.htm) was ap-
plied to the gene axis, and visualized with Treeview
(M. Eisen, http://rana.lbl.gov/EisenSoftware.htm).
Analysis by dCHIP
The analysis data generated by MAS 5.0 was further
processed by dCHIP (Harvard, Boston, MA) for a model-
based analysis18. Each array was normalized against the
baseline array (control) to serve as the basis for ﬁtting
a normalization curve. After calculating model-based
expression values on each array, single or multiple
comparisons were used to ﬁlter inappropriate genes (whose
expression does not vary throughout comparisons) and
hierarchical clustering was performed. dCHIP combines
Affymetrix’s annotation and gene functional classiﬁcation
from LocusLink database (http://www.ncbi.nlm.nih.gov/
LocusLink), which classiﬁes a gene using GeneOntology
terms to identify functional signiﬁcant clusters at clustering
analysis. After the hierarchical clustering is performed on
genes, dCHIP assesses whether a local cluster is enriched
by genes having a particular function based on k-mean or
supervised clusters. P values smaller than 0.005 are
considered signiﬁcant.
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VALIDATION OF IL-1/TGF- EFFECTS IN CHONDROCYTE
CELL LINE H4
The effect of IL-1 on the expression of four MMPs (MMP-
3, -9,-13, -14) was studied in patellar cartilage of adult
C57BL/6 mice. Already 3 h after injection of IL-1 the
expression of the MMPs was enhanced, most pronouncedly
MMP-3 [Table I(B)]. The MMP mRNA levels increased until
12 h, while after 24 h the MMP levels declined and returned
to (nearly) basal levels for MMP-9 and MMP-13.
To study if the chondrocyte cell line reﬂected elevation of
MMP mRNA after IL-1 exposure and whether this cell line
demonstrated TGF-b-induced counteraction of IL-1 effects,
the cells were exposed to IL-1 and TGF-b. Expression of
MMPs in the murine chondrocyte cell line was studied 9 h
after addition of IL-1. This time point was based on a prior
kinetic study comparing various clones of the cell line.
In the chondrocyte cell line, expression of all four MMPs
was elevated after incubation with IL-1 [Table I(C)] as could
be observed in intact patellar cartilage. Compared to cells
incubated without cytokines, TGF-b alone had a clear
inhibitory effect on MMP-13 and MMP-14 levels, while
MMP-3 and MMP-9 levels were unaffected by TGF-b.
TGF-b counteraction against IL-1-induced change was
clear on MMP-13 and MMP-14, as shown by statistical
signiﬁcance. Its effect on MMP-3 and MMP-9 shows
a tendency of counteraction, though not yielding statistical
signiﬁcance. These results indicate that the responses of
the chondrocyte cell line to IL-1 were similar to those of
intact articular cartilage of the mouse. Moreover, its MMP
expression proﬁle in response to IL-1 or TGF-b was in
agreement with literature for a differentiated chondro-
cytes19. These results indicate that the H4 cell line is an
adequate model to study the regulation of gene expression
in chondrocytes by IL-1 and TGF-b.
OVERVIEW OF COMPARATIVE EXPRESSION ANALYSIS
(PAIR-WISE COMPARISON)
The comparative gene expression at 9 h after the
treatments with cytokines was analyzed on oligonucleotide
arrays. This time point was based on a preliminary kinetic
study, and chosen to identify down-stream consequences
of early responses. Expression of MMP genes in these
samples is examined by RT-PCR prior to hybridization to
a GeneChip, and the result conﬁrmed that the responses of
these cells were highly reproducible. The following pair-
wise comparisons were carried out: (1) IL-1 vs control, (2)
TGF-b vs control, (3) TGF-bC IL-1 vs control, (4) TGF-bC
IL-1 vs IL-1, (5) TGF-bC IL-1 vs TGF-b. The scatter plot of
each pair-wise comparison veriﬁed that normalization
conditions used for such comparisons were valid (data not
shown). Table II demonstrates the number of genes
regulated under these conditions. The total gene expres-
sion data are to be found at http://www.rheumaresearch.nl/
takgenearray.html.
Both TGF and IL-1 regulated a large number of genes.
Both counteracted the effect of the other, but the
counteraction by TGF-b on IL-1-regulated genes is more
prominent [Table II(B,C): 38.1% vs 13.7%]. However, the
effect of TGF-b on IL-1-induced changes was not always
counteractive. Some genes appear to be under additive/
synergistic control by IL-1 and TGF-b. Those amounted to
20 out of 339 IL-1-regulated genes [Table II(B): 5.9 %]. The
remaining genes (192 out of 339) were not regulated by theaddition of TGF-b (56.7%). Almost half of the IL-1-regulated
genes were under additional control of TGF-b (38.1%
counteraction, 5.9% enhancement; total 44.0%). In con-
trast, IL-1 affected 14.1% of TGF-b-regulated genes (13.7%
counteraction and 0.6% enhancement). These results
demonstrate that bi-directional interaction exists between
IL-1 and TGF-b at the gene expression level. However,
TGF-b exerts more profound effects on IL-1-regulated
genes than the other way round. It means that the
counteraction is bi-directional but not symmetrical.
CLUSTER ANALYSIS IDENTIFIES CLUSTERS
WITH DIFFERENTIAL TGF-b EFFECT
We then investigated the relationship among the gene
sets under regulation of each cytokine. In Fig. 1(A,B) gene
clusters are represented according to their regulation by
each cytokines. Cluster 1: IL-1 up-regulation, Cluster 2: IL-1
down-regulation, Cluster 3: TGF-b up-regulation, Cluster 4:
TGF-b down-regulation. In Cluster 1, 78 genes are counter-
acted by TGF-b, and 14 genes were up-regulated by TGF-b,
corresponding to the overview shown in Table II. These
sub-clusters are designated as 1A and 1B, respectively, to
clarify the hierarchical relationships. One hundred and
ninety-nine genes up-regulated by IL-1 (Cluster 1) and 373
genes down-regulated by TGF-b (Cluster 3) partially over-
lapped (Cluster 1C). Cluster 1C consisting of 23 genes
partially overlapped with Cluster 1A, but the latter was far
bigger than the former. This indicated that TGF-b counter-
acted genes are not necessarily under the direct regulation
of TGF-b. Fig. 1(B) shows a similar relationship between the
genes down-regulated by IL-1 (Cluster 2) and up-regulated
Table II
Overview of comparative expression analysis. Each column shows
the number of genes up- or down-regulated by a particular
treatment based on pair-wise comparisons. Percentage of genes
receiving counteraction or enhancement is given in bracket.
A. Genes under regulation by IL-1, TGF-b and combination of both
agents compared to the control. B. TGF-b effect on IL-1 regulated
genes based on the comparison between IL-1 and IL-1C TGF-b.
The second column is the same as the second column of A. C. IL-1
effect on TGF-b regulated genes based on the comparisons
between TGF-b and IL-1C TGF-b. The second column is the same
as the third column of A
A. Comparison to control
IL-1 TGF-b IL-1C TGF-b
Up 199 373 286
Down 140 337 309
Total 339 710 595
B. IL-1 vs IL-1C TGF-b
IL-1 TGF-b effect
Counteraction Enhancement No effect
Up 199 78 (39.2%) 14 (7.0%) 109 (54.8%)
Down 140 51 (36.4%) 6 (4.3%) 83 (59.3%)
Total 339 129 (38.1%) 20 (5.9%) 192 (56.7%)
C. TGF-b vs IL-1C TGF-b
TGF-b IL-1 effect
Counteraction Enhancement No effect
Up 373 39 (10.5%) 2 (0.5 %) 332 (89.0%)
Down 337 58 (17.2 %) 2 (0.6 %) 278 (82.5%)
Total 710 97 (13.7%) 4 (0.6%) 610 (85.9%)
430 N. Takahashi et al.: IL-1/TGF-b interaction in chondrocytesFig. 1. Relationship among differentially regulated genes. A) Relationship between genes up-regulated by IL-1 and those down-regulated by
TGF-b. Note that the overlapping region forms the Cluster 1C. B) Relationship between genes down-regulated by IL-1 and those up-regulated
by TGF-b. Cluster names correspond to that described in Table III. Note that the overlapping region forms the Cluster 2C. See text for further
explanation.by TGF-b (Cluster 3). Out of 51 genes of Cluster 2 that are
counter-regulated by TGF-b (Cluster 2A), only a part of
them was directly up-regulated by TGF-b (Cluster 2C).
These observations suggest that the mechanism of in-
teraction involves something broader than direct interaction
between transcription factors.
The relationship among these gene clusters was further
visualized by using software’s Cluster and Treeview
(Fig. 2). Cluster analysis of IL-1 up-regulated genes
identiﬁed two sub-clusters on which TGF-b exerted distinct
effects, corresponding to the clusters deﬁned above. The
sub-cluster 1A contained all genes that were counter-
regulated by TGF-b, and in particular, a majority of themwas concentrated in its sub-cluster 1AA. As shown in
Fig. 2(A), this cluster contained numerous genes related to
inﬂammation and immune function including cytokines and
chemokines. In contrast, the sub-cluster 1B consisted of the
genes that were rather enhanced by TGF-b, and this little
cluster contained a strikingly lot of growth factors [Fig. 2(B)].
FUNCTIONAL CLUSTER ANALYSIS IDENTIFIES NOVEL
CLASSES OF GENES UNDER REGULATION OF TGF-b
The cluster analysis described above suggested that the
differential effect of TGF-b depended on the functional
431Osteoarthritis and Cartilage Vol. 13, No. 5Fig. 2. A tree view representation of the Cluster 1. A hierarchical cluster analysis was performed as described in Materials and methods. Each
row represents a gene and each column represents a sample. The colors represent relative intensity of the signal for each gene in each
sample compared to the average intensity of the entire row; green: decrease, red: increase, black: no change. Cluster 1 consisted of genes up-
regulated by IL-1. Two distinct sub-clusters were named Cluster 1A and 1B, respectively. A. A magniﬁed view of the sub-cluster 1A. The sub-
cluster 1AA contained majority of genes counter-regulated by TGF-b. B. The magniﬁed view of the Cluster 1B. This sub-cluster contained all
genes that are enhanced by TGF-b.classes. In order to evaluate this observation in a statistical
manner functional clustering was performed by using
dCHIP. Table III summarizes the relationship between the
clusters, regulation by either cytokine and gene function
according to the cluster deﬁnition shown in Fig. 1. These
results conﬁrm that some functional classes of genes areselectively regulated by either cytokines. The Cluster 1A
[up-regulated by IL-1 and counteracted by TGF-b, Fig. 2(A)]
is enriched with genes involved in immune/inﬂammatory
responses, chemotaxis and cell cycle arrest [Table III(A)].
The Cluster 1B is signiﬁcantly enriched with genes involved
in cell cycle regulation [Table III(A)], conﬁrming the
432 N. Takahashi et al.: IL-1/TGF-b interaction in chondrocytesFig. 2. (continued).selectivity of the TGF effect. On the other hand, Cluster 1C
(down-regulated by both IL-1 and TGF-b) did not show
particular functional enrichment. Whereas down-regulation
of collagen and extracellular matrix related genes by IL-1
conﬁrms observations reported in the literature, selective
counteraction by TGF-b on genes related to signaling is
observed [Table III(B)]. Cluster 3 identiﬁed potentially novel
classes of target genes under regulation of TGF-b: ras-
GTPase family, core histone, proteasomes and ubiquitin
family [Table III(C)]. Though part of this analysis was based
on protein domain rather than function, this intriguing
observation suggests a role for distinct pathways to which
these classes of genes belong. In addition, regulation by
TGF-b of genes for chaperon, DNA replication, and cell
cycle can partly account for its known anabolic effects.
None of these classes of genes were selectively counter-
regulated or enhanced by the addition of IL-1.
On the other hand, TGF-b down-regulated distinct class
of genes involved in signaling, apoptosis, and neurogenesis
[Table III(D)]. Signiﬁcant enrichment of genes with nuclear
localization suggest functions related to nuclear structure or
transcriptional regulation. No functionally related selectivity
was found for IL-1 counteraction or enhancement.
EXAMPLES OF GENES BELONGING TO FUNCTIONAL CLASSES
As some classes of genes were potentially novel target
genes under regulation of IL-1 or TGF-b, we closely
examined individual genes belonging to these clusters.Table IV enlists some examples of genes according to the
functional cluster. IL-1 up-regulated a large number of
genes involved in immune/inﬂammatory (such as cytokines,
chemokines and inﬂammatory enzymes)/stress responses,
and cell cycle arrest. Stress response genes included those
induced by oxidative stress such as superoxide dismutases
(Sods), DNA damage such as growth arrest and DNA-
damage-inducible 45 (Gadd45) isoforms, and heat shock
such as heat shock proteins (Hsps). Genes involved in cell
cycle arrest included p21 cyclin-dependent kinase inhibitor
1A (Cdki1A), heme oxidase and Gadd isoforms. Although
the majority of these genes involved in inﬂammation were
already known to be under control of IL-1, many genes of
the latter classes are novel target genes for IL-1. All these
groups of genes were largely counteracted by TGF-b
[Cluster 1A, Fig. 2(A)]. In striking contrast, cell cycle
regulators (such as VEGF and CTGF) and protease
inhibitors (TIMP) are enhanced by the addition of TGF-b
[Cluster 1B, Fig. 2(B)]. Remarkable selectivity was also
seen on the genes related to extracellular matrix. TGF-b
exerted an additive effect on all TIMPs (anabolic), while
counteracting the IL-1 effects on all MMPs (catabolic).
Negative effect of IL-1 on other anabolic genes such as
hyaluronan synthase 2 and osteoprotegerin (OPG)
(Tnfrsf11b) was restored by TGF-b, further supporting its
anabolic effect. On the other hand, negative effect of IL-1 on
collagen genes was not inﬂuenced by the addition of TGF-b.
Among adhesion molecules, collagen genes are down-
regulated by IL-1 while those involved in inﬂammation such
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Cluster analysis and functional categoryof genes.Cluster analysiswasperformedasdescribed inMaterials andmethods. For each (sub-) cluster,
pattern of regulation by IL-1, TGF-b, and in combination is described. Significant enrichment of certain functional categories for each cluster is
calculated as described in Materials and methods, and enlisted in the fourth column. P! 0.005 is defined as statistically significant.
A. Clusters up-regulated by IL-1, B. clusters down-regulated by IL-1, C. clusters up-regulated by TGF-b, D. clusters down-regulated by TGF-b.
The relationships among the clusters are shown in Fig. 1
Sub-cluster Regulation Functional category P
(protein domain)
A. Clusters up-regulated by IL-1
1 Up by IL-1 Immune response 0.00056
Inﬂammatory response 0.000007
Defense response 0.002096
Cell cycle arrest 0.00029
Oxidoreductase 0.000909
Transcription factor binding 0.00446
Oxygen and radical metabolism 0.002197
(Ank repeat) 0.000129
(small cytokines) 0
1A TGF-b counteraction Immune response 0.000003
Inﬂammatory response 0.000001
Defense response 0.000118
Chemotaxis 0.001655
Cell cycle arrest 0.000374
Oxidoreductase 0.004067
Stress response 0.000098
1B TGF-b enhancement Cell cycle regulator 0.000083
1C Down by TGF-b e e
B. Cluster 2 and Cluster 3A: down-regulated by IL-1
2 Down by IL-1 Extracellular matrix 0.002376
Cell adhesion 0.004006
Collagen 0.00004
2A TGF-b counteraction Signaling 0.004331
2B TGF-b enhancement e e
2C Up by TGF-b e e
C. Clusters up-regulated by TGF-b
3 Up by TGF-b GTPase 0.003232
Macromolecule biosynthesis 0.002239
Chaperone 0.002043
DNA replication 0.004092
Cell cycle 0.002357
Hydrolase 0.004837
(ras family) 0.00008
(proteasome A-type and B-type) 0
(ubiquitin family) 0.001959
(core histone H2A/H2B/H3/H4) 0.003397
3A IL-1 counteraction e e
3B IL-1 enhancement e e
2C Down by IL-1 e e
D. Clusters down-regulated by TGF-b
4 Down by TGF-b Signaling 0.001268
Nucleus 0.003936
Neurogenesis 0.00404
Apoptosis 0.001693
4A IL-1 counteraction e e
4B IL-1 enhancement e e
1C Up by IL-1 e eas ICAM and VCAM are up-regulated by IL-1, again
pointing to the remarkable selectivity.
As identiﬁed by the functional cluster analysis, number of
genes involved in signaling pathway/signal transduction are
down-regulated by IL-1 and counteracted by TGF-b. Genes
involved in WNT pathway such as Frizzled homologue 8 and
WNT1 inducible signaling pathway protein 2 (Wisp2) were
found in this category. Close look at genes of this category
reveals that TGF-b regulated number of genes related to
TGF signaling pathway as logically expected. Theseincluded TGF-b itself, plasminogen activator inhibitor 1
(Pai1) and SMAD7, largely conﬁrming the literature. As
statistically proven by functional cluster analysis, remarkably
large number of ras-GTPase family of genes was under
positive regulation of TGF-b. Fifteen genes of this family out
of total 79 represented on the chip were found in this cluster,
including ras homolog B (RhoB), Rab7 and Rab23.
Up-regulation of genes involved in ubiquitin/proteasome
pathway by TGF-b is a quite novel and unique observation.
Out of total 18 proteasome genes represented on the chip,
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Examples of functional classes of genes. Representative genes of major functional categories described in Table III are enlisted. Either
a common gene name or gene symbol was used. +TGF-b or +IL-1 means additional effect on IL-1 or TGF-b, respectively. +: up-regulation, :
down-regulation, NC: no change, See http://www.rheumaresearch.nl/takgenearray.html for the original expression data
Gene function and Gene names IL-1 +TGF-b TGF-b +IL-1 Gene function and Gene names IL-1 +TGF-b TGF-b +IL-1
Immune/inﬂammatory response Wnt5a(wnt) NC + + NC
IL6 +    Frizzled homolog 8 (wnt)  + + 
Tnfrsf1b +    PKC, lambda(wnt)  + NC 
Scyb2 (MIP2) +  NC + Wisp2 (wnt)  + NC 
Scya5 (Rantes) +  NC + dickkopf homolog 3 (wnt)  NC NC 
IL-1a +  NC + Rab23 (Ras)  + + NC
complement component C3 +  NC + Rab7 (Ras)  + + NC
Tissue factor +  NC + Ras-like, family 2, locus 9 NC + + NC
Cell cycle arrest ras homolog B, RhoB NC + + NC
Cdki1A (P21) +  NC + Cell cycle
Heme oxygenase +  NC + calmodulin 2 NC NC + NC
Gadd45a +  NC + cyclin-dependent kinase 4 NC NC + NC
Gadd45b +  NC NC Chaperone
Oxidoreductase Hsp, 70 kDa 3 +  NC NC
Ptgs2 (COX2) +  NC + Hsp, 70 kDa 1 +   NC
Nos2 +    Dnajb1 NC NC + NC
Sod2 +  NC + Dnajb9 NC NC + NC
Sod3 +  NC + Ubiquitin/proteasome
Cell cycle regulator Psma2 NC NC + NC
Vegf + + + NC Psma3 NC NC + NC
Vegfc + + + NC Psmb3 NC NC + NC
Ctgf + + + NC Ube2v2 NC NC + NC
Jun-B + + + NC Ubiquitin C NC NC + NC
Extracellular matrix Ube2n NC NC + NC
procollagen, type II, alpha 1  NC NC NC Histone
procollagen, type VI, alpha 3  NC NC NC H3 histone, family 3B NC NC + NC
procollagen, type III, alpha 1  NC NC NC H2A histone, member Z NC NC + NC
Mmp3 +  NC + H2B histone, member S  + + 
Mmp10 +  NC + Nucleus
Mmp12 +  NC + C/EBP, delta +   +
Timp + + + NC Nfkb2 +   +
Timp 2  + +  Nfkbia +   +
Timp 3 NC + + NC Ddit3 +  NC NC
Tnfrsf11b, OPG  + +  Jun-B oncogene + + + NC
Aggrecan 1 NC + + NC Sox4 NC + + NC
hyaluronan synthase 2  + +  Runx1 NC + + NC
Cell adhesion Runx2 NC + + NC
Icam1 +  NC + Rarg NC   NC
Vcam1 +  NC + Cited2 NC   NC
Signaling Rpo2-1 NC   NC
inhibin beta-A (TGF) + NC + NC Apoptosis
Pai1 (TGF) + + + + Tdag51 +  NC +
Tieg (TGF)  + +  Map3k1 +   +
Tgfb1(TGF) NC + +  Tnfrsf1b +   +
Smad 7 (Drosophila) (TGF) NC + + NC Bad NC   NC
Ltbp1(TGF) NC   + Casp12 NC   NC
Bmp4 (TGF) NC   NC Bnip3-like NC   NC
Gene functions are represented in bold.11 of them were found in this cluster. These consisted of
various subunits of both proteasome A-type (Psma) and B-
type (Psmb). Similarly out of total 30 genes related to
ubiquitin, seven are found in this cluster including ubiquitin-
conjugating enzyme E2N (Ube2n) and ubiquitin-conjugating
enzyme E2 variant 2 (Ube2v2). Out of total 11 core histone
genes, six of various subtypes such as H3 histone, family
3B (H3f3b) and H2B histone family, member S (H2bfs) were
in this cluster.
TGF-b down-regulated a large number of genes located
in the nucleus, including those involved in transcription and
transcription regulation such as RNA polymerase II 1
(Rpo2-1), CCAAT/enhancer binding protein (C/EBP)
d (Cebpd) and Cbp/p300-interacting transactivator, with
Glu/Asp-rich carboxy-terminal domain, 2 (Cited2). Analysisof this category of genes again revealed some selectivity in
IL-1/TGF-b interaction. A number of transcription factors
and regulators induced by IL-1 are antagonized by TGF-b.
These included two of the NF-kB family (NF-kB p49 and
IkB) and C/EBP-d, all of which are important for regulation
of genes involved in immune/inﬂammatory responses. Only
one transcription factor found demonstrated rather a syner-
gy than antagonism. This was Jun-B oncogene, which
appeared in Cluster 1B and is also a cell cycle regulator. On
the other hand, the majority of the transcription factors
under control of TGF-b were unaffected by IL-1. These
included runt related transcription factor 1 (runx1) and 2
(runx2) and SRY-box containing gene 4 (Sox4), all of which
are transcription factors involved in bone and cartilage
development20,21.
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The expression regulation of a number of genes was
validated by RT-PCR. We have chosen a number of genes
representing differentially regulated groups in order to
assess possible bias or error involved in original hybridiza-
tion, statistical method and condition of comparisons. (1)
Up-regulated by IL-1 and counteracted by TGF-b (MMP3,
Scyb2, Tdag51, Heme oxygenase, tissue factor), (2) down-
regulated by IL-1 (dickkopf homolog 3), (3) up-regulated by
IL-1 and enhanced by TGF-b (VEGF), (4) up-regulated by
TGF-b (aggrecan, hyaluronan synthase 2, Wnt5a, RhoB,
Psmb3, Histone H3). Table V demonstrates a strong
agreement between the results using GeneChip and the
conventional RT-PCR or quantitative PCR. PCR data
shows slightly larger differences, which could be attribut-
able to the procedure involving exponential ampliﬁcation.
PCR might be more sensitive than GeneChip in detecting
differences as expected, and the result indicates that false
discovery rate in this experiment, if any, is negligibly small.
Discussion
OA is characterized by the destruction of articular
cartilage. In the process of cartilage destruction, activatedchondrocytes producing catabolic factors play a major role.
The exact mechanism of chondrocyte activation is unknown
to date but cellular activation by cytokines and growth
factors present in the osteoarthritic joint is likely to be
involved. The cytokine IL-1 is detected in arthritic joints and
is suggested to be an important activating factor22. The role
of TGF-b, which is also present in osteoarthritic joints23, in
regard to chondrocyte activation remains controversial. To
get more insight in the regulatory effects of IL-1 and TGF-b at
the gene expression level in cartilage we have analyzed the
effect of IL-1 and TGF-b in a chondrocyte cell line.
To validate the mouse chondrocyte cell line H4 as
a suitable system to study IL-1 and TGF-b regulated gene
expression we ﬁrst performed additional study on the
regulation of MMP mRNA expression in this cell line and
in murine articular cartilage in vivo. The chondrocyte cell
lines were rigorously characterized before, and the H4 was
the only cell line which closely resembled the phenotype of
chondrocyte embedded in articular cartilage13. The H4 cell
line showed reproducible elevation of MMP mRNA levels
comparable to in vivo articular cartilage after exposure to
IL-1, and TGF-b counteracted these effects, especially
when grown in monolayer. These results indicated that the
H4 cell line is a valid model to study IL-1 and TGF-b
regulated gene expression in articular chondrocytes.Table V
Validation by semi-quantitative and quantitative PCR. A selected number of genes were tested by semi-quantitative and quantitative RT-PCR.
A. Primer sequences used. B. The result of GeneChip and RT-PCR was compared. I: increase, MI: mild increase, NC: no change, MD: mild
decrease, D: decrease. P-value according to the analysis by MAS 5.0 is indicated in the brackets. See http://www.rheumaresearch.nl/
takgenearray.html for the original expression data. * Quantitative RT-PCR
A.
Gene Gene bank
accession #
Forward primer Reverse primer
Mmp-3* X66402 TGGAGCTGATGCATAAGCCC TGAAGCCACCAACATCAGGA
Heme oxygenase X56824 TGGAGGCTTTGAAGAACCAC TCCACACCATGACTTCCTGA
Scyb2 (ZMIP-2) X53798 TCCAGAGCTTGAGTGTGACG CTTTGGTTCTTCCGTTGAGG
Tdag51 U44081 TCATCACAGTTGCAGGAAGC GAGGAGGTCGCCTACATTCA
Tissue factor M26071 ACGCCCCAAAGTTTTTACCT GTCCTTGAGCCTCGATA
Dickkopf homolog 3 U01063 CTAGGCGGAGAGGAGGAGAT CTGTCTTTCCCAAGCCAGAG
Hyaluronan synthase 2 U52524 GCCTCATCTGTCGAGATGGT ATTCCCAGAGGACCGCTTAT
Vegf M95200 CAGGCTGCTGTAACGATGAA AATGCTTTCTCCGCTCTGAA
Aggrecan* L07049 TCTACCCCAACCAAACCGG AGGCATGGTGCTTTGACAGTG
Wnt5a* M89798 CGCCATGAAGAAGCCCATT CTATAACAACCTGGGCGAAGGA
RhoB* X99963 GGCAGGCCAGGAGGACTAC ACCGAGAAGCACATAAGGATGAC
Psmb3* AW045339 ACACCTGTTTGAAACCATTTCTCA CCTGGTGGTGATCTTGTCTTTCTC
Histone H3* X13605 TCCGTGAAATCAGACGCTATCA TCGCACCAGACGCTGAAAG
Gapdh* NM_008084 GGCAAATTCAACGGCACA GTTAGTGGGGTCTCGCTCCTG
B.
Gene IL-1 IL-1 IL-1 TGF-b TGF-b TGF-b
Affymetrix (P) Affymetrix RT-PCR Affymetrix (P) Affymetrix RT-PCR
Fold change Fold change Fold change Fold change
Mmp-3* I (0) 1.95 2.4 NC (0.5) 1.12 1
Heme oxygenase I (0) 2.58 2 NC (0.5) 1.14 0.5
Scyb2 (ZMIP-2) I (0.000001) 8.28 16 MD (0.997009) 0.75 0.5
Tdag51 I (0) 2.64 4 NC (0.5) 1.23 1
Tissue factor I (0.000437) 2.76 4 NC (0.5) 1.55 1
Dickkopf 3 D (0.999969) 0.46 0.25 NC (0.5) 1.35 1
Hyaluronan synthase 2 D (0.999908) 0.54 0.25 I (0) 4.56 4
Vegf MI (0.002417) 1.92 2 I (0) 4.48 4
Aggrecan* NC (0.5) 0.97 0.77 I (0.000236) 1.91 2.97
Wnt5a* NC (0.588772) 1.05 1.65 I (0.000092) 2.18 4.82
RhoB* NC (0.011266) 1.43 1.37 I (0.000092) 2.01 3.07
Psmb3* NC (0.034854) 1.27 1.19 I (0.000027) 1.66 3.28
Histone H3* NC (0.5) 1.12 1.47 I (0.000789) 1.51 3.25
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throughput gene expression proﬁling, and generated data
on the regulation of a large variety of genes by IL-1 and
TGF-b to a previously unknown extent. As the validation by
RT-PCR demonstrates, the results obtained with this
method were highly reliable. Earlier studies showed early
response genes induced in chondrocytes by IL-1 on cDNA
array containing a limited number of genes24. In the present
study we analyzed the gene expression proﬁle at a later
time point in order to correlate gene expression proﬁle to the
phenotypic changes induced by IL-1 and TGF-b interaction
with it. Our study demonstrates the selective mode of
interaction between IL-1 and TGF-b on gene expression
level. TGF-b counter-regulation on IL-1 effect was more
impressive than the reverse, amounting to almost half of the
IL-1 regulated genes. Less than 15% of the TGF-b-
regulated genes were counter-regulated by IL-1.
The cluster analysis revealed a remarkable selectivity in
the mode of counteraction. IL-1 is strongly pro-inﬂammatory
and exerts catabolic effects on cartilage and isolated
patella, while TGF-b is anti-inﬂammatory, anabolic and
often reverses the effect of IL-125. Selective counteraction
of TGF-b on genes involved in immune/inﬂammatory/
defense/stress responses, cell cycle arrest and proteases
such as Mmps (catabolic) on one hand, and enhancement
on cell cycle regulators and Timps (anabolic) on the other
hand conﬁrm for the ﬁrst time on the genome-wide scale
what was postulated in the literature based on a limited
number of selected genes. Whether this selective enhance-
ment on cell cycle regulators (growth factors) is beneﬁcial
remains to be answered. On the one hand, these genes
may be essential in chondrocyte survival. On the other
hand, VEGF may promote vascular invasion into the
cartilage and enhances MMP production26,27. CTGF is
required for chondrocyte matrix maintenance but also
promotes angiogenesis, vascular invasion and ﬁbrosis28,29.
Enhancement of these genes by TGF-b may lead to
aggravation of IL-1 effects rather than opposite. Identiﬁca-
tion of these down-stream genes that can be responsible for
either protective or aggravating effects enables us to design
future TGF-b based therapeutic strategy.
In addition, we identiﬁed potentially novel classes of
genes under regulation of TGF-b by functional cluster
analysis. As we focused on the functional class rather than
individual genes, potential importance of ras GTPase
signaling and ubiquitin/proteasome pathway is highlighted.
Though recent literature began to emphasize a role for
other signaling pathways besides the well-characterized
SMAD pathway, little is known about the role of ras
GTPases within the TGF-b signaling30. Our ﬁnding identi-
ﬁed ras family members as a signiﬁcant group regulated by
TGF-b, suggesting a link between transcriptional regulation
and cross-talk between signaling pathways. As Rab23
regulates sonic hedgehog (Shh) signaling pathway31, and
the latter is involved in chondrogenesis, such a cross-talk is
a very likely scenario.
Proteasomes are multicatalytic proteinase complexes
involved in ATP/ubiquitin dependent non-lysosomal pro-
teolysis, playing a role in intracellular protein processing.
Controlled proteolysis mediated by the ubiquitin/protea-
some pathway regulates the function of numerous mole-
cules involved in signaling, and thereby integrates
numerous signaling pathways32. TGF-b pathway itself is
under the regulation of ubiquitin/proteasome pathway33.
However, it is a novel observation that ubiquitin/proteasome
pathway is under transcriptional regulation of TGF-b. It is an
attractive hypothesis that the transcriptional regulation ofgenes of the ras GTPases and ubiquitin/proteasome path-
ways is involved in mediating TGF-b signaling and cross-
talk with other pathways. Also genes under opposing
regulation by TGF-b were shown by cluster analysis to be
involved in signal transduction. Another intriguing group
under regulation of TGF-b consists of the histones. Though
the functional consequences of their up-regulation are
unknown, histone subtypes and their exchange largely
inﬂuence nucleosomal architecture and accessibility to
transcription factors34.
IL-1 and TGF-b could counter-regulate a large number of
genes without directly affecting the expression of these
genes as a single agent. It suggested interactions broader
than direct interaction between transcription factors, making
room for novel mechanisms involving ras GTPases,
ubiquitin/proteasome pathway and histones discussed
above. Known interaction involving NF-kB and SMAD35
should undoubtedly play a role in the observed interaction
between IL-1 and TGF-b. Besides this direct interaction,
regulation of genes involved in transcription as shown here
can be another mechanism underlying the interaction
between IL-1 and TGF-b. The TGF-b counteraction on
genes for NF-kB family and C/EBP-d, that regulate a large
number of genes involved in immune/inﬂammatory re-
sponses, conﬁrms the relevance of such a mechanism.
On the other hand, no counter-regulation was exerted by IL-
1 on transcription factors/regulators under control of TGF-b.
This observation partly explains why the counteraction by
TGF-b is more extensive than that by IL-1.
In conclusion, we have demonstrated counteraction as the
dominant mode of interaction between IL-1 and TGF-b.
Selectivity of TGF-b counteraction on inﬂammatory/catabolic
genes conﬁrms a protective role for TGF-b in general. A
small cluster of genes (such as CTGF and VEGF) on which
IL-1 and TGF-b have additive effect is identiﬁed as possible
mediator of adverse effects of TGF-b. Identiﬁcation of
potential novel classes of target genes of TGF-b suggest
their role in complex pathways besides the well-character-
ized SMAD pathway. As the present study was performed on
a mouse chondrocyte cell line at one time point, additional
study may be required before generalizing these conclu-
sions to overall chondrocyte response. Further conﬁrmation
of these down-stream target genes and pathways enables
selective future therapies for destructive joint diseases.
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